Example: Heart Attack

Search clinical trials for: Bosentan

Total 89 results

NCT00631475

Completed

Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443

Conditions: Idiopathic Pulmonary Fibrosis
NCT01721564

Completed

Bosentan and Pulmonary Endothelial Function

Conditions: Pulmonary Arterial Hypertension
NCT02480335

Completed

The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis

Conditions: Scleroderma, Systemic
NCT01662037

Completed

Bosentan Therapy in Children With Functional Single Ventricle

Conditions: Congenital Heart Defects, Functional Single Ventricle
NCT01447550

Completed

Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan

Conditions: Thromboangiitis Obliterans
NCT01425229

Completed

Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin

Conditions: Drug Interactions
NCT01395732

Completed

Bosentan in Systemic Sclerosis

Conditions: Systemic Sclerosis, Digital Ulcers
NCT01223352

Completed

Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension

Conditions: Pulmonary Arterial Hypertension
NCT01241383

Completed

Effect of Bosentan in Scleroderma Renal Crisis

Conditions: Scleroderma Renal Crisis
NCT01184404

Unknown status

Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery

Conditions: Congenital Heart Disease
NCT01270750

Unknown status

Bosentan for Severe Mitral Valve Dysfunction

Conditions: SECONDARY PULMONARY HYPERTENSION, MITRAL STENOSIS, CHILDHOOD RHEUMATOID FEVER, CONGESTIVE HEART FAILURE
NCT00989911

Completed

Endothelin Blockade in Patients With Single Ventricle Physiology

Conditions: Congenital Heart Disease
NCT01338415

Completed

FUTURE 3 Study Extension

Conditions: Pulmonary Arterial Hypertension
NCT00909337

Completed

Early Therapy of Pulmonary Arterial Hypertension

Conditions: Pulmonary Hypertension, Systemic Sclerosis
NCT00864201

Unknown status

A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Conditions: Hypertension, Pulmonary, Connective Tissue Disease
NCT00701597

Completed

Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma

Conditions: Glaucoma, Blood Flow Velocity
NCT00638131

Terminated

Bosentan Use in Patients With Diabetic Nephropathy

Conditions: Type 2 Diabetes
NCT00679068

Terminated

Effects of Bosentan on Respiratory Mechanics

Conditions: Pulmonary Hypertension
NCT00360087

Terminated

A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study

Conditions: Pulmonary Hypertension, Sickle Cell Anemia
NCT00319267

Completed

Bosentan in Children With Pulmonary Arterial Hypertension

Conditions: Pulmonary Arterial Hypertension
NCT00319111

Completed

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Conditions: Pulmonary Hypertension
NCT00319033

Completed

Open-label Study With Bosentan in Interstitial Lung Disease

Conditions: Interstitial Lung Disease, Scleroderma
NCT00319020

Completed

Bosentan in Children With Pulmonary Arterial Hypertension Extension Study

Conditions: Pulmonary Arterial Hypertension
NCT00317486

Completed

Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Conditions: Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
NCT00595049

Completed

Pulmonary Artery Remodelling With Bosentan

Conditions: Hypertension, Pulmonary